Edwards Lifesciences Corp. (EW): Price and Financial Metrics
EW Price/Volume Stats
| Current price | $69.28 | 52-week high | $94.87 |
| Prev. close | $69.96 | 52-week low | $67.13 |
| Day low | $69.11 | Volume | 3,608,700 |
| Day high | $70.44 | Avg. volume | 3,187,034 |
| 50-day MA | $77.34 | Dividend yield | N/A |
| 200-day MA | $81.45 | Market Cap | 42.12B |
EW Stock Price Chart Interactive Chart >
EW POWR Grades
- EW scores best on the Quality dimension, with a Quality rank ahead of 93.22% of US stocks.
- The strongest trend for EW is in Momentum, which has been heading down over the past 177 days.
- EW ranks lowest in Momentum; there it ranks in the 23rd percentile.
EW Stock Summary
- EDWARDS LIFESCIENCES CORP's market capitalization of $42,347,449,458 is ahead of 94.67% of US-listed equities.
- Price to trailing twelve month operating cash flow for EW is currently 45.03, higher than 92.04% of US stocks with positive operating cash flow.
- With a price/sales ratio of 7.49, EDWARDS LIFESCIENCES CORP has a higher such ratio than 86.97% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to EDWARDS LIFESCIENCES CORP are TEL, ZBRA, TRMB, GLW, and KEYS.
- EW's SEC filings can be seen here. And to visit EDWARDS LIFESCIENCES CORP's official web site, go to www.edwards.com.
EW Valuation Summary
- EW's price/sales ratio is 7.5; this is 294.74% higher than that of the median Healthcare stock.
- Over the past 243 months, EW's price/earnings ratio has gone down 11.6.
Below are key valuation metrics over time for EW.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| EW | 2023-09-22 | 7.5 | 6.6 | 30.5 | 25.9 |
| EW | 2023-09-21 | 7.5 | 6.7 | 30.7 | 26.1 |
| EW | 2023-09-20 | 7.7 | 6.9 | 31.5 | 26.7 |
| EW | 2023-09-19 | 7.8 | 7.0 | 31.9 | 27.1 |
| EW | 2023-09-18 | 7.8 | 7.0 | 31.9 | 27.1 |
| EW | 2023-09-15 | 7.9 | 7.0 | 32.0 | 27.2 |
EW Growth Metrics
- Its 4 year net cashflow from operations growth rate is now at 90.86%.
- Its 5 year revenue growth rate is now at 42.34%.
- Its 2 year revenue growth rate is now at 19.48%.
The table below shows EW's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-12-31 | 5,382.4 | 1,218.2 | 1,521.9 |
| 2022-09-30 | 5,363.8 | 1,309 | 1,458.8 |
| 2022-06-30 | 5,355 | 1,531 | 1,455.4 |
| 2022-03-31 | 5,357.1 | 1,724.9 | 1,538.5 |
| 2021-12-31 | 5,232.5 | 1,732.1 | 1,503.1 |
| 2021-09-30 | 5,094.5 | 1,758.5 | 1,477.3 |
EW's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- EW has a Quality Grade of B, ranking ahead of 92.8% of graded US stocks.
- EW's asset turnover comes in at 0.681 -- ranking 53rd of 186 Medical Equipment stocks.
- ATRS, SRDX, and ANGO are the stocks whose asset turnover ratios are most correlated with EW.
The table below shows EW's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.681 | 0.755 | 0.381 |
| 2021-03-31 | 0.647 | 0.752 | 0.229 |
| 2020-12-31 | 0.661 | 0.754 | 0.231 |
| 2020-09-30 | 0.678 | 0.755 | 0.235 |
| 2020-06-30 | 0.693 | 0.750 | 0.233 |
| 2020-03-31 | 0.744 | 0.744 | 0.370 |
EW Price Target
For more insight on analysts targets of EW, see our EW price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $119.36 | Average Broker Recommendation | 1.62 (Moderate Buy) |
Edwards Lifesciences Corp. (EW) Company Bio
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility due to be completed in 2021 in Limerick, Ireland. (Source:Wikipedia)
Latest EW News From Around the Web
Below are the latest news stories about EDWARDS LIFESCIENCES CORP that investors may wish to consider to help them evaluate EW as an investment opportunity.
Edwards Lifesciences Corp (EW): A Deep Dive into Financial Metrics and Competitive StrengthsUnpacking the Growth and Competitive Edges of Edwards Lifesciences Corp (EW) |
Edwards Lifesciences (EW): A Deep Dive into Its Significant UndervaluationUnraveling the True Value of Edwards Lifesciences (EW) |
ITGR or EW: Which Is the Better Value Stock Right Now?ITGR vs. EW: Which Stock Is the Better Value Option? |
Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt ResponsiblyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility... |
Edwards Lifesciences Corp (EW): A Deep Dive into Its Financial Metrics and Competitive StrengthsUnpacking the Growth and Competitive Edges of Edwards Lifesciences Corp (EW) |
EW Price Returns
| 1-mo | -9.30% |
| 3-mo | -24.28% |
| 6-mo | -16.73% |
| 1-year | -16.16% |
| 3-year | -12.28% |
| 5-year | 28.22% |
| YTD | -7.14% |
| 2022 | -42.41% |
| 2021 | 42.00% |
| 2020 | 17.32% |
| 2019 | 52.31% |
| 2018 | 35.90% |
Continue Researching EW
Here are a few links from around the web to help you further your research on Edwards Lifesciences Corp's stock as an investment opportunity:Edwards Lifesciences Corp (EW) Stock Price | Nasdaq
Edwards Lifesciences Corp (EW) Stock Quote, History and News - Yahoo Finance
Edwards Lifesciences Corp (EW) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...